|
Short Title: ACCL1931
Enrollment Status: Recruiting
NCT #: NCT05602194
Specialty Area: Pediatric Hematology/Oncology
Conditions Studied: Leukemia; Lymphoma
Age Groups: Child; Adult
Phase: III
To determine in a randomized manner whether the addition of levocarnitine prophylaxis to asparaginase-containing regimens will decrease the incidence of conjugated hyperbilirubinemia during ALL induction therapy for adolescents and young adults
Location: Renown Health, Office of Clinical Research
Address:
Complete Study Details: https://clinicaltrials.gov/study/NCT05602194
Disclaimer: This listing gives you general information about the study and isn't part of the official consent process. If you decide to learn more, the research team will talk with you and check if you meet any additional requirements to join the study.
